Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Change in Accured Expenses: 2011-2025

Historic Change in Accured Expenses for Sonoma Pharmaceuticals (SNOA) over the last 14 years, with Mar 2025 value amounting to $295,000.

  • Sonoma Pharmaceuticals' Change in Accured Expenses fell 1409.38% to -$419,000 in Q1 2013 from the same period last year, while for Mar 2013 it was -$141,000, marking a year-over-year decrease of 194.00%. This contributed to the annual value of $295,000 for FY2025, which is 32.88% up from last year.
  • Per Sonoma Pharmaceuticals' latest filing, its Change in Accured Expenses stood at $295,000 for FY2025, which was up 32.88% from $222,000 recorded in FY2024.
  • In the past 5 years, Sonoma Pharmaceuticals' Change in Accured Expenses registered a high of $679,000 during FY2022, and its lowest value of -$668,000 during FY2021.
  • Its 3-year average for Change in Accured Expenses is $214,667, with a median of $222,000 in 2024.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first tumbled by 302.42% in 2021, then soared by 201.65% in 2022.
  • Sonoma Pharmaceuticals' Change in Accured Expenses (MRY) stood at -$668,000 in 2021, then skyrocketed by 201.65% to $679,000 in 2022, then crashed by 81.30% to $127,000 in 2023, then soared by 74.80% to $222,000 in 2024, then skyrocketed by 32.88% to $295,000 in 2025.
  • Its last three reported values are $295,000 in FY2025, $222,000 for FY2024, and $127,000 during FY2023.